Login Start free

Focus

Drug Discovery Investors: Angels and VC Firms

The RaiseHunt database lists 4,683 Drug Discovery investors: 239 angel investors and 4,444 people at 1,313 firms. Most list Seed and Series A among their stages; the largest hubs are New York, San Francisco and Boston.

Strongest in New York, San Francisco and Boston

Common stages: Seed and Series A

4,683: Drug Discovery investors
239: Angel investors
4,444: People at VC/PE firms
1,313: Firms tagged

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

4,683 Drug Discovery investors

Showing 761-780

Filters

Viewing

Drug Discovery4,683

Investor Type

Choosing one replaces Drug Discovery.

Investment Stage

Choosing one replaces Drug Discovery.

Seed84,745
Series A53,997
Late-Stage37,937
Series B35,865
Growth34,738
Pre-Seed32,477

Investment Profile

Choosing one replaces Drug Discovery.

SaaS63,483
FinTech54,183
Healthcare53,462
Consumer46,735
AI46,189
Hardware36,507
Commerce32,773
Climate23,313
Real Estate17,905
Education13,608
Food10,848
Travel7,450
Energy946
Agriculture555

Country

Choosing one replaces Drug Discovery.

City

Choosing one replaces Drug Discovery.

Focus1

Investor	Location	Type	Markets	Contact	Actions
Jason Park Partner at Flagship Pioneering	Cambridge, United States	AcceleratorVenture capital	AIClimate		View profile
Jillian Shaw Venture Partner at Magnetic Ventures	Cambridge, United States	Venture capital	AIConsumer		View profile
Adam Goulburn Co-Founder at DIMENSION	New York, United States	Venture capital	AIHealthcare		View profile
Tunde Akinniranye Digital Health Unit at Nestlé Health Science	Chicago, United States	Corporate VC	FoodHealthcare		View profile
Aymeric Rabot Fellow at South Park Commons	Tampa, United States	AcceleratorSyndicate / Angel group	AICommerce		View profile
Geoffrey von Maltzahn General Partner at Flagship Pioneering	Cambridge, United States	AcceleratorVenture capital	AIClimate		View profile
Craig H. Boyce Managing Partner at ALS Investment Fund	Boston, United States	Venture capital	Healthcare		View profile
Francis X. Suarez President at Alpha Wave Global	United States	Private equityVenture debt	AICommerce		View profile
Glenn Rockman Founder and Managing Partner at Adjuvant Capital	New York, United States	Private equityVenture capital	ClimateFinTech		View profile
Alexander Hall-Daniels Principal at SOSV SF & NY (Fka IndieBio)	New York, United States	AcceleratorVenture capital	ClimateFood		View profile
Joseph Chittenden-Veal Investor at Visionary Venture Fund	New York, United States	Venture capital	Healthcare		View profile
Gladys Nunez Executive Director Amgen Ventures at Amgen	Cambridge, United States	Corporate VC	AIHardware		View profile
Sam Bisbee VP, Information Security at Draftkings	Boston, United States	Corporate VCVenture capital	AICommerce		View profile
Cyril Ebersweiler Founder / Managing Director at SOSV HAX	Singapore	AcceleratorVenture capital	AIClimate		View profile
Laura Deming Partner at Age1	Palo Alto, United States	Venture capital	Healthcare		View profile
Shawn Broderick General Partner at Dlab	Newtonville, United States	AcceleratorVenture capital	AIClimate		View profile
Dimitri Krainc Chairman at Northwestern Medicine	Chicago, United States	Corporate VCPrivate equity	AIHardware		View profile
Diya Malhotra Principal at Abingworth	London, United Kingdom	Venture capital	Healthcare		View profile
Kurt von Emster Managing Partner at Abingworth	Menlo Park, United States	Operator-ledVenture capital	Healthcare		View profile
RoseAnn B. Rosenthal Co-Founder and Chair at Broad Street Angels	Philadelphia, United States	Government-backedSyndicate / Angel group	AIClimate		View profile

Data: RaiseHunt investor dataset · Snapshot 26 September 2026 · How this data is built · Report a correction or request removal